Search

MSK researchers and collaborators have developed a new type of CAR T cell designed to attack a cell surface protein called uPAR — allowing them to target both tumors and cancer-supporting cells in the tumor microenvironment.

… Monday, March 30, 2026 Chimeric antigen receptor T-cell therapy — CAR T for short — has been a major advance in treating blood cancers like leukemia and lymphoma. But the immunotherapy has struggled against solid tumors for two main reasons: tumor cells often don’t share one consistent surface target

Today MSK issued a statement regarding its financial results for its fiscal year 2025.

… Tuesday, March 31, 2026 MSK reported a deficiency of operating revenues over expenses totaling ($47.9) million and an operating cash flow margin of 3.7% for 2025. These results reflect planned one-time investments related to the go-live of the Epic electronic health record (EHR) system alongside higher

A rare form of stomach cancer caused by an inherited gene mutation can be avoided by having the stomach removed — and many people can adjust to life afterward.

… Wednesday, November 16, 2016 Summary People with an inherited mutation in the CDH1 gene are at a very high risk of developing a rare type of stomach cancer . Having the stomach removed, which can be performed using minimally invasive methods, can eliminate this risk. Most people recover well from the

Learn about MSK’s Adolescent and Young Adult program, which is uniquely positioned to help patients like Danielle Leventhal.

… Thursday, October 1, 2020 Tyler Wong’s girlfriend first sensed something was off. In April 2020, the couple was cuddling at home when girlfriend Joanhy felt a lump in Tyler’s belly. Tyler felt it too. Thinking it could be a hernia, Joanhy asked the urologist she works for to examine Tyler. The doctor

Five Memorial Sloan Kettering (MSK) faculty were named today to the prestigious Fellows of the American Association for Cancer Research (AACR) Academy Class of 2022.

… Tuesday, March 22, 2022 Five Memorial Sloan Kettering (MSK) faculty are among the 33 international scientific leaders elected today to the prestigious Fellows of the American Association for Cancer Research (AACR) Academy class of 2022. Luis Alberto Diaz Jr., MD; Thomas J. Kelly, MD, PhD; Nikola P. Pavletich

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the American Association for Cancer Research (AACR) Annual Meeting on April 8-13 in New Orleans, La.

… Wednesday, April 6, 2022 Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the American Association for Cancer Research (AACR) Annual Meeting on April

Dr. Diane Reidy-Lagunes speaks with Dr. John Mulhall, Director of the Male Sexual and Reproductive Medicine Program at MSK and editor-in-chief of The Journal of Sexual Medicine, to discuss the impacts of cancer and its treatment on men’s sexual health.

… Thursday, March 3, 2022 Men’s sexual dysfunction is common during cancer treatment, so why doesn’t anyone talk about it? The medical team treating a cancer too often fails to address the potential impact on the patient’s sex life, despite the fact that it can be essential for emotional well-being. If

Learn why Bobby Logan chose active surveillance for his prostate cancer, and how he was successfully treated after his tumor changed.

… Friday, September 24, 2021 Urologist Behfar Ehdaie believes that active surveillance is a viable option for many patients with prostate cancer . He feels so strongly about this idea that several years ago, he sought out negotiation experts from Harvard Business School and asked to learn techniques he

A new study is challenging the perception that mesothelioma affects only older men. Learn why MSK experts say the medical community should be aware of this rare cancer's early symptoms.

… Tuesday, March 31, 2026 Mesothelioma , a rare cancer that usually starts in the lining around the lungs, has long been thought of as a condition that affects older men — especially those who may have been exposed to asbestos while working in manufacturing or construction. About 3,300 people are diagnosed

Learn about the clinical trials and research at MSK that led to FDA approvals in 2025, expanding treatment options for a range of different cancers.

… Monday, December 15, 2025 The U.S. Food and Drug Administration (FDA) approved 10 cancer drugs in 2025, based on clinical trials in which MSK played a pivotal role.  These approvals spanned therapies for a range of solid tumors and blood cancers and included treatments for both common and rare types